Wondering how to move funds from another retirement account into a Roth IRA? Here’s what you need to know. Many, or all, of the products featured on this page are from our advertising partners who ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...

The Seattle Seahawks tied the Los Angeles Rams in the fourth quarter off one of the strangest plays you'll ever see ... and yet another reminder to play through the whistle. Down 30-28 with 6:23 left ...

“1000-lb Sisters” fans have been watching Tammy and Amy Slaton’s journey for years, but is the TLC reality series coming to an end? The “1000-lb Sisters” season 7 finale aired in June, and season 8 ...

Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...

Last year saw twice as much Manhattan office space start to be converted into apartments as the year before – a boom that’s poised to change the chemistry of Midtown neighborhoods historically ...

The practice surged in the 1980s and 1990s, before medical groups began warning it was harmful. By Ellen Barry As a teenager, Julie Rodgers attended Tuesday night group therapy sessions in which young ...

Roughly two blocks from Manhattan’s Grand Central Terminal, construction workers are stripping down the former Pfizer Inc. headquarters to its columns, beams and concrete slabs. The office towers are ...

LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning. The CNS-focused biotech ...

Despite the stagnant biotech IPO market of the last six months, LB Pharmaceuticals has set out plans to reel in hundreds of millions of dollars through its upcoming public debut. The ...

Many drugs are available for schizophrenia, but insufficient efficacy and intolerable side effects leave an unmet need that biotech companies are still trying to fill. LB Pharmaceuticals is not ...

Conversion disorder is a psychiatric condition in which a person develops physical symptoms that are not under voluntary control and are not explained by a neurological disease or another medical ...